Strategic decision-making is a notoriously nebulous process, based on as much feeling and experience as hard fact. By incorporating the modelling skills developed over more than fifteen years in the health economics sector, CATALYST can remove some of the uncertainty from the strategic planning process. Integrating health economics data into product development and marketing programmes has already enabled confident decisions to be taken in ’stop-go’ development, pricing, reimbursement and market entry.
CATALYST can take this to the next level. Modelling data gleaned from clinical trials, markets, financial sectors and so on, allows CATALYST to project outcomes into the future to provide clients with a vision of the healthcare system, market size and structure in five, ten or even twenty years where required. Such models are invaluable to robust decision-making based on sound evidence and confidence of outcomes.